Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jan;2(1):6-19.
doi: 10.5812/nephropathol.8971. Epub 2013 Jan 1.

Treatment of renal manifestations of ANCA-associated vasculitis

Kresimir Galesic  1 , Danica Ljubanovic  2 , Ivica Horvatic  1
Affiliations
Review

Treatment of renal manifestations of ANCA-associated vasculitis

Kresimir Galesic et al. J Nephropathol. 2013 Jan.

Abstract

Context: Vasculitis is a clinicopathological entity characterized by inflammation and necrosis of blood vessels.

Evidence acquisitions: Directory of Open Access Journals (DOAJ), Google Scholar, Pubmed (NLM), LISTA (EBSCO) and Web of Science have been searched.

Results: Two major autoantigens for ANCA are myeloperoxidase (MPO) and proteinase 3 (PR3), which are proteins in the primary granules of neutrophils and in the lysosomes of monocytes. They are expressed in mature neutrophils of patients with ANCA, while absent in healthy subjects.

Conclusions: The kidney is the most commonly affected vital organ in ANCA-associated vasculitis, and patient outcomes are largely determined by the severity of renal disease at diagnosis and by its response to treatment.

Keywords: ANCA-associated small-vessel vasculitis; Antineutrophil cytoplasmatic autoantibody; Chapel Hill Consensus Conference classification; Crescentic glomerulonephritis; Vasculitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Figure 2
Figure 2
See this image and copyright information in PMC

References

    1. Mansi IA, Opran A, Rosner F . ANCA-Associated Small-Vessels Vasculitis. Am J Physician 2002;60:1615-20. Available at:http://www.ncbi.nlm.nih.gov/pm...
    1. Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int . 2007;56:87–96. - PubMed
    1. Passen P, Tervaert JW, Heeringa P. Mechanisms of vasculitis: How Pauci-Immune is ANCA-Associated renal Vasculitis. Nephron Exp Nephrol . 2007;105:e10–e16. - PubMed
    1. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL. et al. Nomenclature of systemic vasculitidesProposal of an international consensus conference. Arthritis Rheum . 1994;37(2):187–92. - PubMed
    1. Nachman PH, Jennette JC, Falk RJ. Vasculitic diseases of the Kidney in Schrier W. R., Gottoschalk W.C.. Diseases of the Kidney&Urinary tract. 8. 2. Philadelphia: Lippincott Williams&Wilkins; 2007. p. 1748-75.

LinkOut - more resources